Prometheus Biosciences Inc logo

Prometheus Biosciences Inc Share Price Today (NASDAQ: RXDX)

Prometheus Biosciences Inc share price is $0 & ₹0.00 as on 14 Jun 2023 IST

-199.92

(-100%)

Market is closed - opens 7 PM, 02 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 15 Jun 2023

View live Prometheus Biosciences Inc share price in Dollar and Rupees. Guide to invest in Prometheus Biosciences Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Prometheus Biosciences Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Prometheus Biosciences Inc (RXDX) Key Statistics

in dollars & INR

Previous Close
$199.92
Open
$199.68
Market Capitalization
$9.6B
Today's Volume
$1.9M
Revenue TTM
$4.0M
EBITDA
$-161.6M
Earnings Per Share (EPS)
$-3.54
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-33.3%

How to invest in Prometheus Biosciences Inc Stock (RXDX) from India?

It is very easy for Indian residents to invest directly in Prometheus Biosciences Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Prometheus Biosciences Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Prometheus Biosciences Inc or RXDX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Prometheus Biosciences Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Prometheus Biosciences Inc shares which would translate to null fractional shares of Prometheus Biosciences Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Prometheus Biosciences Inc, in just a few clicks!

Global Institutional Holdings in Prometheus Biosciences Inc

  • RTW INVESTMENTS, LLC

    6.84%

  • BlackRock Inc

    5.87%

  • Vanguard Group Inc

    5.68%

  • Boxer Capital LLC

    3.97%

  • 72 Investment Holdings, LLC

    3.87%

  • Cormorant Asset Management, LLC

    3.46%

Analyst Recommendation on Prometheus Biosciences Inc

Rating
Trend

Hold

    40%Buy

    60%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Prometheus Biosciences Inc(by analysts ranked 0 to 5 stars)

About Prometheus Biosciences Inc

Prometheus Biosciences, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated interstitial lung disease. The company also develops PR300, a G-protein coupled receptor modulator for IBD and potentially other immune-mediated diseases; PRA052, an anti-CD30L mAb for IBD; PR1100, an anti-cytokine receptor mAb for IBD and other immune-mediated diseases; and PR2100, an anti-inflammatory cytokine mAb for IBD, and inflammatory and fibrotic diseases. It has a diagnostics development and collaboration agreement with Takeda Pharmaceutical Company Limited; co-development and manufacturing agreement with Dr. Falk Pharma GmbH for PRA052; license agreement with Cedars-Sinai Medical Center; and strategic collaboration with Millennium Pharmaceuticals, Inc. The company was formerly known as Precision IBD, Inc. and changed its name to Prometheus Biosciences, Inc. in October 2019. Prometheus Biosciences, Inc. was incorporated in 2016 and is headquartered in San Diego, California.
Organization
Prometheus Biosciences Inc
Employees
97
CEO
Mr. Mark C. McKenna
Industry
Miscellaneous

Important FAQs about investing in RXDX Stock from India :

Can Indians buy Prometheus Biosciences Inc shares?

Yes, Indians can invest in the Prometheus Biosciences Inc (RXDX) from India.

With INDmoney, you can buy Prometheus Biosciences Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Prometheus Biosciences Inc at zero transaction cost.

How can I buy Prometheus Biosciences Inc shares from India?

It is very easy to buy Prometheus Biosciences Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Prometheus Biosciences Inc (RXDX) be purchased?

Yes, you can buy fractional shares of Prometheus Biosciences Inc with INDmoney app.

What are the documents required to start investing in Prometheus Biosciences Inc stocks?

To start investing in Prometheus Biosciences Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Prometheus Biosciences Inc?

Today's market capitalisation of Prometheus Biosciences Inc RXDX is 9.6B

Who is the Chief Executive Officer (CEO) of Prometheus Biosciences Inc ?

Mr. Mark C. McKenna is the current Chief Executive Officer (CEO) of Prometheus Biosciences Inc.